Skip to main content
ConductScienceScienceDex

Wei Zhang

FY2026 NIH rank #7,583
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10383047Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0003-0875-263XVerified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Public Health

NIH Funding · FY2026

Linked Award Amount
$2.5M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#7,583
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Wei Zhang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$2M

3 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Wei Zhang as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA300666-01A1R01Co-investigator
    Advancing early colorectal cancer diagnosis and risk stratification using DNA methylation markers
    University of Chicago · Internal Medicine (NIH department code)
    $692.1K
    award amount
  • 5U01CA297685-02U01Co-investigator
    A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis
    University of Chicago · Internal Medicine (NIH department code)
    $676.5K
    award amount
  • 5R01CA280637-04R01Co-investigator
    Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma
    University of Chicago · Public Health (NIH department code)
    $643.1K
    award amount
  • 1R01MD021741-01A1R01Co-investigator
    Elucidating novel epigenetic etiology of risk disparities in multiple myeloma
    University of Chicago · Public Health (NIH department code)
    $481.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing Wei Zhang as a PI.

FY2026 award administered by University of Chicago (IL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Chicago
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #9723
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Wei Zhang.

Brian C-H Chiu
University of Chicago
7
shared awards
Benjamin Derman
University of Chicago
3
shared awards
Bruce Marc Bissonnette
University of Chicago
3
shared awards

Explore further

Find collaborators for Wei Zhang

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Wei Zhang | NIH Award Records | ConductScience